Extracorporeal photopheresis in the treatment of patients with refractory chronic graft-versus-host disease after allogeneic bone marrow transplantation
- Authors: Bykova TA1, Kozlov AV1, Stancheva NV1, Semenova EV1, Kulagina II1, Bondarenko SN1, Vavilov VN1, Morozova EV1, Zubarovskaia LS1, Afanas'ev BV1
-
Affiliations:
- Институт детской онкологии, гематологии и трансплантологии им. Р.М. Горбачевой, СПбГМУ им. акад. И.П. Павлова
- Issue: Vol 85, No 8 (2013)
- Pages: 60-68
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/31325
- ID: 31325
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
T A Bykova
Институт детской онкологии, гематологии и трансплантологии им. Р.М. Горбачевой, СПбГМУ им. акад. И.П. Павлова
A V Kozlov
Институт детской онкологии, гематологии и трансплантологии им. Р.М. Горбачевой, СПбГМУ им. акад. И.П. Павлова
N V Stancheva
Институт детской онкологии, гематологии и трансплантологии им. Р.М. Горбачевой, СПбГМУ им. акад. И.П. Павлова
E V Semenova
Институт детской онкологии, гематологии и трансплантологии им. Р.М. Горбачевой, СПбГМУ им. акад. И.П. Павлова
I I Kulagina
Институт детской онкологии, гематологии и трансплантологии им. Р.М. Горбачевой, СПбГМУ им. акад. И.П. Павлова
S N Bondarenko
Институт детской онкологии, гематологии и трансплантологии им. Р.М. Горбачевой, СПбГМУ им. акад. И.П. Павлова
V N Vavilov
Институт детской онкологии, гематологии и трансплантологии им. Р.М. Горбачевой, СПбГМУ им. акад. И.П. Павлова
E V Morozova
Институт детской онкологии, гематологии и трансплантологии им. Р.М. Горбачевой, СПбГМУ им. акад. И.П. Павлова
L S Zubarovskaia
Институт детской онкологии, гематологии и трансплантологии им. Р.М. Горбачевой, СПбГМУ им. акад. И.П. Павлова
B V Afanas'ev
Институт детской онкологии, гематологии и трансплантологии им. Р.М. Горбачевой, СПбГМУ им. акад. И.П. Павлова
References
- Lee S.J. Have we made progress in the management of chronic graft-vs-host disease? Best Pract Res Clin Haematol 2010; 23 (4): 529-535.
- Shulman H.M., Sullivan K.M., Weiden P.L. et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204-217.
- Pavletic S.Z., Martin P., Lee S.J. et al. Response Criteria Working Group Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report. Biol Blood Marrow Transplant 2006; 12 (3): 252-266.
- Filipovich A.H., Weisdorf D., Pavletic S. et al. National Institutes of Health consensus development project on criteria for clinical trials in chron- ic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11 (12): 945-956.
- Koc S., Leisenring W., Flowers M.E. et al. Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone. Blood 2002; 100: 48-51.
- Martin P.J., Weisdorf D., Przepiorka D. et al. Design of Clinical Trials Working Group. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group report. Biol Blood Marrow Transplant 2005 12 (5): 491-505.
- Wolff D., Schleuning M., von Harsdorf S. et al. Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease. Biol Blood Marrow Transplant 2011; 17 (1): 1-17.
- Dignan F.L., Amrolia P., Clark A. et al. Diagnosis and management of chronic graft-versus-host disease. Br J Haematol 2012; 158: 46-61.
- Couriel D., Carpenter P.A., Cutler C. et al. Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group report. Biol Blood Marrow Transplan 2006; 12 (4): 375-396.
- Dignan, F.L., Greenblatt, D., Cox. M. et al. Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous GVHD. Bone Marrow Transplant 2012; 47 (6): 824-830.
- Greinix H.T., Socie G., Bacigalupo A. et al. Assessing the potential role of photopheresis in hematopoietic stem cell transplant. Bone Marrow Transplant 2006; 38 (4): 265-273.
- Seaton E.D., Szydlo R.M., Kanfer E. et al. Influence of extracorporeal photopheresis on clinical and laboratory parameters in chronic graft-versus-host disease and analysis of predictors of response. Blood 2003; 102 (4): 1217-1223.
- Foss F.M., DiVenuti G.M., Chin K. et al. Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors. Bone Marrow Transplant 2005; 35 (12): 1187-1193.
- Child F.J., Ratnavel R., Watkins P. et al. Extracorporeal photopheresis (ECP) in the treatment of chronic graft-versus-host disease (GVHD). Bone Marrow Transplant 1999; 23 (9): 881-887.
- Apisarnthanarax N., Donato M., Kobling M. et al. Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility an/RESULTS: Bone Marrow Transplant 2003; 31 (3): 459-465.
- Messina C., Locatelli F., Lanino E. et al. Extracorporeal photochemotherapy for paediatric patients with graft-versus-host disease after haematopoietic stem cell transplantation. Br J Haematol 2003; 122 (1): 118-127.
- Scarisbrick J. Extracorporeal photopheresis: what is it and when should it be used? Clin Exper Dermatol 2009; 34 (7): 757-760.
- Flowers M.E., Apperley J.F., van Besien K. et al. A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease. Blood 2008; 112 (7): 2667-2674.
- Greinix H.T., van Besien K., Elmaagacli A.H. et al. UVADEX Chronic GVHD Study Group. Progressive improvement in cutaneous and extracutaneous chronic graft-versus-host disease after a 24-week course of extracorporeal photopheresis - results of a crossover randomized study. Biol Blood Marrow Transplant 2011; 17 (12): 1775-1782.
- Couriel D.R., Hosing C., Saliba R. et al. Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD. Blood 2006; 107 (8): 3074-3080.
- Hautmann A.H., Wolff D., Hahn J. et al. Extracorporeal photopheresis in 62 patients with acute and chronic GVHD: Results of treatment with the COBE Spectra System. Bone Marrow Transplant 2013; 48 (3): 439-445. doi: 10.1038/bmt.2012.156
![](/img/style/loading.gif)